# A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis

> **NCT04171765** · PHASE2 · TERMINATED · sponsor: **Genentech, Inc.** · enrollment: 46 (actual)

## Conditions studied

- Non-alcoholic Steatohepatitis

## Interventions

- **DRUG:** Placebo
- **DRUG:** BFKB8488A

## Key facts

- **NCT ID:** NCT04171765
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-09-30
- **Primary completion:** 2023-01-23
- **Final completion:** 2023-01-23
- **Target enrollment:** 46 (ACTUAL)
- **Why stopped:** The study was terminated due to strategic business reasons.
- **Last updated:** 2024-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04171765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04171765, "A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04171765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*